Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Top Cited Papers
Open Access
- 1 June 2010
- Vol. 51 (6), 1069-1077
- https://doi.org/10.1111/j.1528-1167.2009.02397.x
Abstract
To improve patient care and facilitate clinical research, the International League Against Epilepsy (ILAE) appointed a Task Force to formulate a consensus definition of drug resistant epilepsy. The overall framework of the definition has two “hierarchical” levels: Level 1 provides a general scheme to categorize response to each therapeutic intervention, including a minimum dataset of knowledge about the intervention that would be needed; Level 2 provides a core definition of drug resistant epilepsy using a set of essential criteria based on the categorization of response (from Level 1) to trials of antiepileptic drugs. It is proposed as a testable hypothesis that drug resistant epilepsy is defined as failure of adequate trials of two tolerated, appropriately chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom. This definition can be further refined when new evidence emerges. The rationale behind the definition and the principles governing its proper use are discussed, and examples to illustrate its application in clinical practice are provided.This publication has 36 references indexed in Scilit:
- Remission of epilepsy after two drug failures in children: A prospective studyAnnals of Neurology, 2009
- Strategies to detect adverse effects of antiepileptic drugs in clinical practiceEpilepsy & Behavior, 2008
- Likelihood of seizure remission in an adult population with refractory epilepsyAnnals of Neurology, 2007
- Patient-perceived impact of resective epilepsy surgeryNeurology, 2006
- How long does it take for epilepsy to become intractable? A prospective investigationAnnals of Neurology, 2006
- Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhoodBrain, 2004
- Early development of intractable epilepsy in childrenNeurology, 2001
- Adverse drug reactions: definitions, diagnosis, and managementThe Lancet, 2000
- Restricted driving for people with epilepsyNeurology, 1999
- Commission on Outcome Measurement in Epilepsy, 1994–1997: Final ReportEpilepsia, 1998